What is Deltagen Inc. (DGEN) stock price today?

Deltagen Inc. (DGEN) is currently trading at $0.00.

What is DGEN P/E ratio?

Deltagen Inc.'s P/E ratio is 0.04. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is DGEN return on equity (ROE)?

Deltagen Inc.'s return on equity (ROE) is -2.72%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Deltagen Inc.'s market cap?

Deltagen Inc. has a market capitalization of $3859.

OTC · Biotechnology

Deltagen Inc. (DGEN) Stock

$0.00 OTC: DGEN Healthcare

Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry.

Valuation

Metric	Value
Price	$0.00
Market Cap	$3859
P/E Ratio	0.04
P/B Ratio	0.00
P/S Ratio	3.57
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-2.72%
ROA	-1.58%
ROCE	4.42%
Gross Margin	99.48%
Operating Margin	29.28%
Net Margin	-5.97%
Debt/Equity	0.01
Current Ratio	1.45

Annual Financials (USD)

Metric	2009	2010	2012	2013	2014
Revenue	$1.0M	$2.0M	$1.0M	$1.0M	$0
Operating Profit	$-1.0M	$-1.0M	$0	$0	$0
Net Profit	$-1.0M	$-1.0M	$-1.0M	$-4.0M	$0
EPS	$0.00	$0.00	$0.00	$0.00	$0.00
Op Margin	-51.8%	-34.9%	-5.0%	11.0%	29.3%

Balance Sheet (USD)

Metric	2009	2010	2012	2013	2014
Total Assets	$8.0M	$7.0M	$6.0M	$2.0M	$2.0M
Total Liabilities	$0	$0	$0	$0	$0
Cash	$6.0M	$4.0M	$0	$0	$0
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2009	2010	2012	2013	2014
Operating Cash Flow	$-1.0M	$-2.0M	$-1.0M	$0	—
Investing Cash Flow	$0	$0	$0	$0	—
Financing Cash Flow	$0	$-1.0M	$-1.0M	$0	—
Net Cash Flow	$0	$0	$0	$0	—
Free Cash Flow	$-1.0M	$-2.0M	$-1.0M	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.37
FCF Yield	0.00%
Quick Ratio	2.30
Interest Coverage	0.00
Return 1Y	0.00%
Return 3Y	0.00%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CVHIFVentura Cannabis & Wellness Corporation	$0.00	—	0.00	$3704	0.00%
CYPSCyclo3pss Corporation	$0.00	—	—	$4054	0.00%
NMRDNemaura Medical Inc.	$0.00	—	0.00	$4035	0.00%
NMXSNet Medical Xpress Solutions, Inc.	$0.00	—	-0.01	$26367	0.00%
QMDTQuick-Med Technologies, Inc.	$0.00	—	-0.04	$29877	0.00%

About Deltagen Inc.

Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.

Deltagen Inc. (DGEN) stock trades at $0.00 with a market capitalization of $3859. The stock is valued at a price-to-earnings (P/E) ratio of 0.04, price-to-book of 0.00, price-to-sales of 3.57. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Deltagen Inc. generates a return on equity (ROE) of -2.72%, return on capital employed of 4.42%, an operating margin of 29.28%, a net profit margin of -5.97%.

Official website: www.d-gen.co.il

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides